Catalyst Pharmaceuticals, Inc. (CPRX)
23.32
+0.04
(+0.15%)
USD |
NASDAQ |
Dec 31, 16:00
23.32
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap: 2.867B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Collegium Pharmaceutical, Inc. | 1.464B |
| ACADIA Pharmaceuticals, Inc. | 4.516B |
| Amicus Therapeutics, Inc. | 4.392B |
| Rigel Pharmaceuticals, Inc. | 776.88M |
| Krystal Biotech, Inc. | 7.154B |
Market Cap Related Metrics
| PE Ratio | 13.61 |
| PS Ratio | 5.122 |
| PEG Ratio | 0.2944 |
| Price to Book Value | 3.115 |
| Price to Free Cash Flow | 12.63 |
| Price | 23.32 |
| Earnings Yield | 7.35% |
| PEGY Ratio | 0.2944 |
| Operating PE Ratio | 11.44 |
| Normalized PE Ratio | 13.81 |